drugset / Trial / NCT06712290

Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy

NCT06712290 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of the study is to see which is better at treating patients which rotator cuff tendinopathy (RCT): a single injection of Connective Tissue Matrix boost (CTM) or a steroid shot. Patients will be randomized (like flipping a coin) to the treatment. Patients and researchers will be blinded (not know) what group the patients are in. Patients will come back to the study clinic at 6 weeks, 3 months and 6 months after the shot to answer questionnaires, have a physical exam, and complete physical function tests to check their shoulder.

Timeline

Start
2024-11-25
Primary completion
2025-12-17
Completion
2025-12-17

Outcome

Outcome not reported

Stopped: “No participants met eligibility and the study was closed.”

Drugs

EvaluationDrugModalityDoseRoute
Subject CTM Boost Other / unclassified 2 ml Other
Comparator Kenalog-40 Other / unclassified 2 ml Other

Indications